Utah Medical Products Inc UTMD.O :
* UTMD REPORTS AUDITED YEAR 2018 AND FOURTH QUARTER
FINANCIAL
PERFORMANCE
* UTAH MEDICAL PRODUCTS INC QTRLY EARNINGS PER SHARE $0.905
* UTAH MEDICAL PRODUCTS INC QTRLY NET SALES $9.8 MILLION
VERSUS
$10.2 MILLION
* UTAH MEDICAL PRODUCTS INC QTRLY EPS BEFORE GILTI TAX$0.940
* UTAH MEDICAL PRODUCTS INC - "EXPECTS WORLDWIDE
MACROECONOMIC
CONDITIONS TO WEAKEN, WHICH MAY AFFECT DEMAND FOR DISCRETIONARY
SPECIALTY MEDICAL DEVICES"
* UTAH MEDICAL PRODUCTS INC - "CONTINUING TRADE WAR WITH
CHINA
COULD HAVE SIGNIFICANT ADVERSE EFFECTS ON UTMD"
* UTAH MEDICAL PRODUCTS INC - "ON SUBJECT OF BREXIT, UTMD
DOES NOT
FORESEE A MATERIAL IMPACT ON ITS FINANCIAL RESULTS IN 2019"
* UTAH MEDICAL PRODUCTS INC - CURRENTLY PROJECTS UTMD 2019
USD
CONSOLIDATED REVENUES MAY BE IN RANGE OF 9-10% HIGHER THAN IN
2018
* UTAH MEDICAL PRODUCTS INC - "CURRENTLY PROJECTS UTMD 2019
USD
CONSOLIDATED REVENUES MAY BE IN RANGE OF 9-10% HIGHER THAN IN
2018"
Source text for Eikon: ID:nGNX5kn2CJ
Further company coverage: UTMD.O